Extendicare Inc. (TSE:EXE – Get Free Report)’s share price passed above its 200-day moving average during trading on Tuesday . The stock has a 200-day moving average of C$10.32 and traded as high as C$13.17. Extendicare shares last traded at C$13.09, with a volume of 111,826 shares.
Wall Street Analysts Forecast Growth
EXE has been the topic of several recent research reports. Royal Bank of Canada upped their target price on shares of Extendicare from C$9.50 to C$11.00 and gave the company a “sector perform” rating in a research report on Thursday, November 28th. Cormark upgraded Extendicare to a “moderate buy” rating in a research report on Wednesday, February 19th. BMO Capital Markets lifted their target price on Extendicare from C$11.00 to C$13.50 in a report on Monday, March 3rd. Finally, TD Securities boosted their target price on Extendicare from C$10.50 to C$13.00 and gave the company a “hold” rating in a research report on Monday, March 3rd.
Check Out Our Latest Stock Analysis on Extendicare
Extendicare Price Performance
Extendicare Announces Dividend
The firm also recently announced a monthly dividend, which was paid on Monday, March 17th. Stockholders of record on Monday, March 17th were paid a dividend of $0.04 per share. The ex-dividend date of this dividend was Friday, February 28th. This represents a $0.48 dividend on an annualized basis and a dividend yield of 3.67%. Extendicare’s dividend payout ratio is 61.20%.
Extendicare Company Profile
Extendicare Inc, operating solely in Canada, is the largest private-sector owner and operator of long-term care (LTC”) homes and one of the largest private-sector providers of publicly funded home health care services.
See Also
- Five stocks we like better than Extendicare
- Investing in Construction Stocks
- Penny Stock SurgePays Rises 70%: 1 Reason to Buy, 5 to SellĀ
- What is the S&P/TSX Index?
- Top 3 Beverage Stocks Pouring Out Profits
- What is a Death Cross in Stocks?
- CarMax and Carvana: Steering the Used Car Market
Receive News & Ratings for Extendicare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Extendicare and related companies with MarketBeat.com's FREE daily email newsletter.